Oren Cohen, M.D.

Equibles does not estimate personal net worth.

About Oren Cohen, M.D.

Fortrea Holdings Inc. reported in an 8-K filed July 3, 2023 that Oren Cohen, M.D. was appointed Chief Medical Officer and President, Clinical Pharmacology, effective June 29, 2023. Fortrea Holdings Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fortrea Holdings Inc. includes Anshul Thakral (CEO and Board Member), Peter M. Neupert (CEO and Board Member), Thomas Pike (CEO, Chairman and Board Member) and 7 others.

“On June 29, 2023, the following people were appointed as officers of the Company serving in the office of the Company set forth beside each person's name:”

Fortrea Holdings Inc. Form 8-K, filed July 3, 2023 · Read the filing

Affiliation history

Fortrea Holdings Inc. (FTRE)
SEC 8-K

Current
2023-06-29–present

Company network

Fortrea Holdings Inc.

FTRE

Current role

Biotechnology · Healthcare

Leadership on record at Fortrea Holdings Inc.

Anshul Thakral CEO, Board Member
Peter M. Neupert CEO, Board Member
Thomas Pike CEO, Chairman, Board Member
Jason F. Knoblauch CFO
Jill McConnell CFO
Mark Morais COO
Amanda Warren Chief Accounting Officer
Carrie Russell Chief Accounting Officer
Robert A. Parks Chief Accounting Officer
Amrit Ray Board Member

Recent activity

Executive change Appointed: Chief Medical Officer and President, Clinical Pharmacology Fortrea Holdings Inc. (FTRE)
2023-06-29